| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † † Approved by the ESMO Guidelines Committee: August 2002, last update January 2020. This publication supersedes the previously published version—Ann Oncol. 2013;24(suppl 6):vi138–vi143.
|
Heuser, M.
|
|
|
31 |
6 |
p. 697-712
|
artikel
|
| 2 |
Addressing the blind spot of cancer care innovation: health inequity
|
Nabi, J.
|
|
|
31 |
6 |
p. 668-670
|
artikel
|
| 3 |
Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19
|
Qu, J.
|
|
|
31 |
6 |
p. 825-826
|
artikel
|
| 4 |
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
|
Haanen, J.
|
|
|
31 |
6 |
p. 724-744
|
artikel
|
| 5 |
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment †
|
Fabi, A.
|
|
|
31 |
6 |
p. 713-723
|
artikel
|
| 6 |
Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients
|
Rubinstein, J.C.
|
|
|
31 |
6 |
p. 815-821
|
artikel
|
| 7 |
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
|
Lamberti, G.
|
|
|
31 |
6 |
p. 807-814
|
artikel
|
| 8 |
Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA
|
Grellety, T.
|
|
|
31 |
6 |
p. 822-823
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
31 |
6 |
p. iv
|
artikel
|
| 10 |
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
|
Paluch-Shimon, S.
|
|
|
31 |
6 |
p. 674-696
|
artikel
|
| 11 |
Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
|
Hui, E.P.
|
|
|
31 |
6 |
p. 769-779
|
artikel
|
| 12 |
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
|
Schuler, M.
|
|
|
31 |
6 |
p. 789-797
|
artikel
|
| 13 |
Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
|
Jiang, Y.
|
|
|
31 |
6 |
p. 760-768
|
artikel
|
| 14 |
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
|
Paz-Ares, L.
|
|
|
31 |
6 |
p. 798-806
|
artikel
|
| 15 |
Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma
|
Moreno, V.
|
|
|
31 |
6 |
p. 780-788
|
artikel
|
| 16 |
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|
Liu, M.C.
|
|
|
31 |
6 |
p. 745-759
|
artikel
|
| 17 |
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy
|
Bolze, P.-A.
|
|
|
31 |
6 |
p. 823-825
|
artikel
|
| 18 |
Table of Contents
|
|
|
|
31 |
6 |
p. ii-iii
|
artikel
|
| 19 |
The legacy of Professor Aron Goldhirsch
|
Gelber, R.D.
|
|
|
31 |
6 |
p. 671-673
|
artikel
|
| 20 |
Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?
|
Bailleux, C.
|
|
|
31 |
6 |
p. 665-667
|
artikel
|
Tijdschrift beschrijving